Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

13.4%

9 terminated/withdrawn out of 67 trials

Success Rate

80.0%

-6.6% vs industry average

Late-Stage Pipeline

18%

12 trials in Phase 3/4

Results Transparency

44%

16 of 36 completed trials have results

Key Signals

4 recruiting16 with results6 terminated

Enrollment Performance

Analytics

N/A
20(37.7%)
Phase 2
16(30.2%)
Phase 4
8(15.1%)
Phase 1
4(7.5%)
Phase 3
4(7.5%)
Early Phase 1
1(1.9%)
53Total
N/A(20)
Phase 2(16)
Phase 4(8)
Phase 1(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (67)

Showing 20 of 67 trials
NCT02023333Phase 2Completed

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

Role: collaborator

NCT06030622Phase 1Recruiting

Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

Role: lead

NCT06087029Not ApplicableRecruiting

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

Role: collaborator

NCT02839915Phase 2Active Not Recruiting

Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

Role: collaborator

NCT04060030Phase 2Recruiting

Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism

Role: collaborator

NCT04060017Phase 2Active Not Recruiting

Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium

Role: collaborator

NCT04322734Recruiting

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Role: collaborator

NCT01208662Phase 3Active Not Recruiting

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Role: collaborator

NCT05439772Phase 4Completed

Examining the Effect of Ondansetron on Bowel Prep Success

Role: lead

NCT00207454Phase 1Completed

Optimizing Strategies to Improve STD Partner Services

Role: collaborator

NCT04755595Phase 2Completed

Combination Facial Aesthetic Treatment in Millennials

Role: lead

NCT05796167Early Phase 1Withdrawn

Pimavanserin for Sleep in Parkinson Disease

Role: lead

NCT03654248Not ApplicableCompleted

"Let's Get Organized" in Adult Psychiatric/habilitation Care

Role: collaborator

NCT00773773Not ApplicableTerminated

Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer

Role: collaborator

NCT06374407Not ApplicableNot Yet Recruiting

The MIND-GUT Digital Pilot Intervention Study

Role: collaborator

NCT05916534Not ApplicableUnknown

We Care About Brooklyn - A Digital Behavioral Intervention to Optimize Engagement in Maternal Healthcare

Role: lead

NCT06119152Not ApplicableUnknown

Digital Equity for Stroke Approach

Role: lead

NCT05288218Not ApplicableWithdrawn

Evaluation of Leak-free Bronchoscope Adapter

Role: collaborator

NCT05977400Phase 3Not Yet Recruiting

NICU Antibiotics and Outcomes (NANO) Follow-up Study

Role: collaborator

NCT03607175Phase 2Unknown

Adjunctive Treatment for Chronic Rhinosinusitis With Nasal Polyposis

Role: collaborator